14963645

Source:http://linkedlifedata.com/resource/pubmed/id/14963645

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020431, umls-concept:C0039082, umls-concept:C1292733, umls-concept:C1801960
pubmed:issue	6
pubmed:dateCreated	2004-6-1
pubmed:abstractText	This study investigated the effects of hyperbaric oxygen (HBO) therapy on the cardiovascular alteration (e.g. mean arterial pressure, vascular reactivity of thoracic aorta rings changes) caused by zymosan in rats.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14963645-15034647
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7704851
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/3-nitrotyrosine, http://linkedlifedata.com/resource/pubmed/chemical/Malondialdehyde, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Nos2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine, http://linkedlifedata.com/resource/pubmed/chemical/Zymosan
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0342-4642
pubmed:author	pubmed-author:CaputiAchille PAP, pubmed-author:CuzzocreaSalvatoreS, pubmed-author:De AngelisAntonellaA, pubmed-author:FilippelliAmeliaA, pubmed-author:ImperatoreFrancescoF, pubmed-author:LiguoriGiovanniG, pubmed-author:LuongoCarloC, pubmed-author:RossiFrancescoF, pubmed-author:ScafuroAntonellaA
pubmed:issnType	Print
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1175-81
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:14963645-Analysis of Variance, pubmed-meshheading:14963645-Animals, pubmed-meshheading:14963645-Aorta, pubmed-meshheading:14963645-Endothelium, Vascular, pubmed-meshheading:14963645-Hyperbaric Oxygenation, pubmed-meshheading:14963645-Immunohistochemistry, pubmed-meshheading:14963645-Male, pubmed-meshheading:14963645-Malondialdehyde, pubmed-meshheading:14963645-Multiple Organ Failure, pubmed-meshheading:14963645-Nitric Oxide Synthase, pubmed-meshheading:14963645-Nitric Oxide Synthase Type II, pubmed-meshheading:14963645-Random Allocation, pubmed-meshheading:14963645-Rats, pubmed-meshheading:14963645-Rats, Sprague-Dawley, pubmed-meshheading:14963645-Tyrosine, pubmed-meshheading:14963645-Vascular Diseases, pubmed-meshheading:14963645-Vasodilation, pubmed-meshheading:14963645-Zymosan
pubmed:year	2004
pubmed:articleTitle	Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.
pubmed:affiliation	Department of Experimental Medicine, Faculty of Medicine, Section of Pharmacology L. Donatelli, Second University of Naples, Naples, Italy.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies